• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund II - Biotechnology Sub-Fund

+ Add to Watchlist

CARBIOA:LX

29.07 EUR

As of 00:00:00 ET on 10/31/2014.

Snapshot for Carnegie Fund II - Biotechnology Sub-Fund (CARBIOA)

Year To Date: +40.64% 3-Month: +21.33% 3-Year: +45.59% 52-Week Range: 20.61 - 29.07
1-Month: +7.95% 1-Year: +49.15% 5-Year: +35.03% Beta vs CXBT: -

Mutual Fund Chart for CARBIOA

No chart data available.
  • CARBIOA:LX 29.07
  • 1M
  • 1Y
Interactive CARBIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARBIOA

Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.

Inception Date: 10-10-2000 Telephone: 352-40-40-30-1
Managers: ULF ARVIDSSON
Web Site: www.carnegieam.com

Fundamentals for CARBIOA

NAV (on 2014-10-31) 29.07
Assets (M) (on 2014-10-31) 27.19
Fund Leveraged N
Minimum Investment 15,000.00
Minimum Subsequent Investment -

Dividends for CARBIOA

No dividends reported

Fees & Expenses for CARBIOA

Front Load -
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.10

Top Fund Holdings for CARBIOA

Filing Date: 09/30/2014
Name Position Value % of Total
Gilead Sciences Inc 26,547 2,237,652 8.903%
Vertex Pharmaceuticals Inc 24,508 2,179,532 8.672%
Celgene Corp 26,948 2,022,452 8.047%
Biogen Idec Inc 6,276 1,643,878 6.540%
Alexion Pharmaceuticals Inc 12,090 1,587,423 6.316%
BioMarin Pharmaceutical Inc 20,658 1,180,387 4.696%
Medivation Inc 14,987 1,173,329 4.668%
Jazz Pharmaceuticals PLC 8,959 1,138,952 4.531%
Regeneron Pharmaceuticals Inc 3,983 1,137,077 4.524%
Mylan Inc/PA 30,708 1,106,107 4.401%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil